Abstract:We designed active anticancer agents (3 a–j) based on coumarin‐quinazolinone. In testing on A‐549 and MDA‐MB‐231 cell lines, 3 i excelled against A‐549 (IC50 7.11 μM), and 3 g outperformed doxorubicin in MDA‐MB‐231 (IC50 5.12 μM). HEK293 cytotoxicity confirmed safety. Molecular docking showed favorable interactions with Topo IIα ATPase/AMP‐PNP. SwissADME assessed ADME properties. Cancer remains a complex global threat causing widespread deaths. Developing effective anticancer agents despite advancements still remained challenging. In this work it is designed and synthesised therapeutically active anticancer agents based on coumarin‐quinazolinone 5(a–j) through nucleophilic substitution reaction of 4‐bromomethyl coumarin derivatives with 6,7‐bis(2‐methoxyethoxy)quinazolin‐4(3H)‐one and characterised by using FTIR, 1HNMR, 13C NMR and LCMS analysis. The compounds 5(a–j) were screened for in vitro anticancer activity against A‐549 lung cancer cell lines and MDA‐MB‐231 cell lines. Compound 5i emerged as the most promising antiproliferative candidate demonstrating an IC50 value of 7.11 μM against A‐549 cell lines. Meanwhile compound 5g found as a hit candidate in the case of MDA‐MB‐231, exhibiting an IC50 of 5.12 μM, surpassing the potency of the standard drug doxorubicin (IC50 5.89 μM). Further, the safety profile of coumarin‐quinazolinone scafolds (5a–j) were examined for their cytotoxicity towards human embryonic kidney cell lines (HEK293). It was found that the most active compounds exhibited good safety profile towards human embryonic cell lines. Additionally, molecular docking investigations confirmed that compounds 5(a–j) exhibited elevated docking scores and demonstrated favourable interactions with the HER2 (PDB:3PP0) and VEGFR2 (PDB:4ASE). Furthermore, we investigated the ADME properties using the SwissADME tool.

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Design, Synthesis, Antimicrobial, and Anticancer Activities of Acridine Thiosemicarbazides Derivatives

Design, Synthesis, Biological Activity and Molecular Docking Study of Coumarin Derivatives Bearing 2-Methylbiphenyl Moiety

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Design, Synthesis and Biological Evaluation of a Series of New Resveratrol Analogues As Potential Anti-Cancer Agents

Design and Synthesis of Potent Anticancer Agents Using Coumarin‐Quinazolinone Based Scaffolds: Exploration of ADME Properties and Molecular Docking Studies

Design, Synthesis, and in Vitro Evaluation of Novel 3, 7‐disubstituted Coumarin Derivatives As Potent Anticancer Agents

Design, Synthesis and Biological Evaluation of Novel 3-Substituted 4-Anilino-coumarin Derivatives As Antitumor Agents

Design, synthesis and evaluation of acridine derivatives as multi-target Src and MEK kinase inhibitors for anti-tumor treatment.

Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro

Design, Synthesis and Anticancer Activity of a New Series of <i>N</i>-aryl-<i>N</i>-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N′-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives

Design and Synthesis of Acridine-Triazole and Acridine-Thiadiazole Derivatives and Their Inhibitory Effect against Cancer Cells

Design, synthesis and cytotoxic evaluation of novel betulonic acid-diazine derivatives as potential antitumor agents

Design, Syntheses and Biological Evaluation of Natural Product Aiphanol Derivatives and Analogues: Discovery of Potent Anticancer Agents

Design, Synthesis, Antitumor Activity Evaluation, and Molecular Dynamics Simulation of Some 2-Aminopyrazine Derivatives

Design, Synthesis, and Anticancer Activity Studies of Novel Quinoline-Chalcone Derivatives

Design, Synthesis and Anti‐Tumor Activity Evaluation of Novel 3,4‐(methylenedioxy)cinnamic Acid Amide‐Dithiocarbamate Derivatives

Design, Synthesis And Biological Evaluation Of Novel Bromophenol Derivatives Incorporating Indolin-2-One Moiety As Potential Anticancer Agents